JP2022515820A5 - - Google Patents
Info
- Publication number
- JP2022515820A5 JP2022515820A5 JP2021537704A JP2021537704A JP2022515820A5 JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5 JP 2021537704 A JP2021537704 A JP 2021537704A JP 2021537704 A JP2021537704 A JP 2021537704A JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- pharmaceutical composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018146029A RU2711871C3 (ru) | 2018-12-25 | Моноклональные антитела, которые специфически связываются с участком бета цепи семейства TRBV-9 Т-клеточного рецептора человека, и способы их применения | |
| RU2018146029 | 2018-12-25 | ||
| PCT/RU2019/050257 WO2020139171A1 (ru) | 2018-12-25 | 2019-12-24 | Моноклональные антитела, специфически связывающиеся с trbv-9 человека |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515820A JP2022515820A (ja) | 2022-02-22 |
| JP2022515820A5 true JP2022515820A5 (enExample) | 2023-01-10 |
| JP7507160B2 JP7507160B2 (ja) | 2024-06-27 |
Family
ID=69184146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537704A Active JP7507160B2 (ja) | 2018-12-25 | 2019-12-24 | ヒトｔｒｂｖ９に特異的に結合するモノクローナル抗体 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US12297269B2 (enExample) |
| EP (2) | EP3904387B1 (enExample) |
| JP (1) | JP7507160B2 (enExample) |
| KR (1) | KR20210118843A (enExample) |
| CN (1) | CN113692412B (enExample) |
| AR (1) | AR117735A1 (enExample) |
| AU (1) | AU2019416787A1 (enExample) |
| BR (1) | BR112021012550A2 (enExample) |
| CA (1) | CA3124800A1 (enExample) |
| CL (1) | CL2021001704A1 (enExample) |
| CO (1) | CO2021008204A2 (enExample) |
| CR (1) | CR20210353A (enExample) |
| EA (1) | EA202100199A1 (enExample) |
| EC (1) | ECSP21046332A (enExample) |
| IL (1) | IL284367A (enExample) |
| JO (1) | JOP20210168B1 (enExample) |
| MA (1) | MA53688B1 (enExample) |
| MX (1) | MX2021007718A (enExample) |
| MY (1) | MY206214A (enExample) |
| NZ (1) | NZ778430A (enExample) |
| PE (1) | PE20211792A1 (enExample) |
| PH (1) | PH12021551535A1 (enExample) |
| SG (1) | SG11202106974SA (enExample) |
| WO (1) | WO2020139171A1 (enExample) |
| ZA (1) | ZA202104356B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2694412C9 (ru) * | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| CA3105448A1 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| GB2599228B (en) | 2019-02-21 | 2024-02-07 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| CN119039441A (zh) | 2019-02-21 | 2024-11-29 | 马伦戈治疗公司 | 与nkp30结合的抗体分子及其用途 |
| AU2020416273A1 (en) | 2020-01-03 | 2022-07-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
| WO2025075529A1 (en) * | 2023-10-04 | 2025-04-10 | Joint Stock Company "Biocad" | Antibody binds to trbv5-1 segment of human tor domain |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223426A (en) | 1988-12-15 | 1993-06-29 | T Cell Sciences, Inc. | Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| US5766947A (en) | 1988-12-14 | 1998-06-16 | Astra Ab | Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| WO2010151416A1 (en) | 2009-06-25 | 2010-12-29 | Fred Hutchinson Cancer Research Center | Method of measuring adaptive immunity |
| WO2012008397A1 (ja) | 2010-07-12 | 2012-01-19 | 第一三共株式会社 | 抗ｅｐｈａ２抗体及びその用途 |
| US20130273089A1 (en) | 2011-11-03 | 2013-10-17 | Tolera Therapeutics, Inc. | Antibody and methods for selective inhibition of t-cell responses |
| PL2991683T3 (pl) | 2013-05-02 | 2020-03-31 | Glykos Finland Oy | Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem |
| EP3202784A1 (en) * | 2016-02-08 | 2017-08-09 | Polybiocept AB | T-cell receptor sequences for active immunotherapy |
| KR102436129B1 (ko) | 2016-06-17 | 2022-08-26 | 메디진 이뮤노테라피스 게엠바하 | T 세포 수용체 및 이의 용도 |
| RU2019116312A (ru) | 2016-11-14 | 2020-12-14 | Фред Хатчинсон Кэнсер Рисерч Сентер | Высокоаффинные tcr, специфичные к t-антигену полиомавируса клеток меркеля, и их применения |
| US20200040085A1 (en) * | 2017-02-27 | 2020-02-06 | Chugai Seiyaku Kabushiki Kaisha | Anti-hla-dq2.5/8 antibody and its use for the treatment of celiac disease |
| CN107502671B (zh) * | 2017-10-12 | 2020-05-05 | 中国医学科学院肿瘤医院 | 利用trbv家族成员预测曲妥珠单抗新辅助治疗乳腺癌患者疗效试剂盒及其应用 |
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
-
2019
- 2019-12-23 AR ARP190103841A patent/AR117735A1/es unknown
- 2019-12-24 MY MYPI2021003582A patent/MY206214A/en unknown
- 2019-12-24 EP EP19904442.1A patent/EP3904387B1/en active Active
- 2019-12-24 MX MX2021007718A patent/MX2021007718A/es unknown
- 2019-12-24 JP JP2021537704A patent/JP7507160B2/ja active Active
- 2019-12-24 EA EA202100199A patent/EA202100199A1/ru unknown
- 2019-12-24 KR KR1020217023567A patent/KR20210118843A/ko active Pending
- 2019-12-24 US US17/417,570 patent/US12297269B2/en active Active
- 2019-12-24 AU AU2019416787A patent/AU2019416787A1/en active Pending
- 2019-12-24 CA CA3124800A patent/CA3124800A1/en active Pending
- 2019-12-24 SG SG11202106974SA patent/SG11202106974SA/en unknown
- 2019-12-24 NZ NZ778430A patent/NZ778430A/en unknown
- 2019-12-24 BR BR112021012550-7A patent/BR112021012550A2/pt unknown
- 2019-12-24 CR CR20210353A patent/CR20210353A/es unknown
- 2019-12-24 MA MA53688A patent/MA53688B1/fr unknown
- 2019-12-24 CN CN201980092914.6A patent/CN113692412B/zh active Active
- 2019-12-24 PE PE2021001079A patent/PE20211792A1/es unknown
- 2019-12-24 WO PCT/RU2019/050257 patent/WO2020139171A1/ru not_active Ceased
- 2019-12-24 EP EP26157540.1A patent/EP4721817A2/en active Pending
-
2021
- 2021-06-23 CO CONC2021/0008204A patent/CO2021008204A2/es unknown
- 2021-06-24 IL IL284367A patent/IL284367A/en unknown
- 2021-06-24 CL CL2021001704A patent/CL2021001704A1/es unknown
- 2021-06-24 ZA ZA2021/04356A patent/ZA202104356B/en unknown
- 2021-06-24 JO JOJO/P/2021/0168A patent/JOP20210168B1/ar active
- 2021-06-24 EC ECSENADI202146332A patent/ECSP21046332A/es unknown
- 2021-06-25 PH PH12021551535A patent/PH12021551535A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515820A5 (enExample) | ||
| JP2022532274A5 (enExample) | ||
| EP3645742B1 (en) | Anti-ror1 antibodies and methods of making and using thereof | |
| RU2504553C2 (ru) | Антитела к her | |
| JP2021058215A (ja) | Ｒｏｒ１癌の治療および転移の阻害に使用するための抗体およびワクチン | |
| RU2451689C2 (ru) | Новые антипролиферативные антитела | |
| JP2020532965A5 (enExample) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| RU2013102225A (ru) | АНТИТЕЛА ПРОТИВ Axl И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2014503189A5 (enExample) | ||
| HRP20240102T1 (hr) | Monoklonsko protutijelo koje antagonizira i inhibira vezanje između humanog pd-1 antigena i njegovog liganda, postupak njegove priprave i primjena | |
| JP2010526028A5 (enExample) | ||
| JP2016520520A5 (enExample) | ||
| JP2022551836A (ja) | Ｂｃｍａを標的とする抗体、二重特異性抗体及びその用途 | |
| JP2013520984A5 (enExample) | ||
| US20250313630A1 (en) | Ph-selective anti-cd3 antibodies and use of the same | |
| SA515360248B1 (ar) | أجسام مضادة cd26 واستخداماتها | |
| WO2017186182A1 (en) | Humanized anti-basigin antibodies and the use thereof | |
| JP2022516071A5 (enExample) | ||
| JP2018502068A5 (enExample) | ||
| AU2023200728A1 (en) | Prevention or treatment method for peripheral neuropathy or pain accompanying disease in which peripheral neuropathy or astrocyte disorder is recognized | |
| JP2009524428A5 (enExample) | ||
| JP2024028850A (ja) | 抗ｐｄ－ｌ１抗体及びその製薬用途 | |
| WO2014139425A1 (zh) | 一种抗Blys的单克隆抗体及含有该抗体的药物组合物 | |
| IL277899B1 (en) | Methods and compositions for treating yellow fever |